New York, New York - May 06, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has released an announcement outlining its ...
As Silverback admits defeat, ARS troops forward to fund commercialization of epinephrine nasal spray
ARS Pharmaceuticals is backing onto Nasdaq through a reverse merger with Silverback Therapeutics to bag cash to commercialize an epinephrine nasal spray and win market share from the incumbent EpiPen.
Silverback Therapeutics will lay off 27% of its workforce and close its oncology program, the Seattle company announced Thursday in its fourth quarter earnings report. The company reported ...
Silverback AI Chatbot has announced the expansion of its platform with a refined version of its AI Agents framework, marking another step toward scalable, intelligent automation for businesses. This ...
About Silverback Therapeutics Silverback Therapeutics, Inc. is a biopharmaceutical company focused on leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered and ...
Featured Image for Silverback United, Inc. MIAMI, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Silverback United, Inc. (trading under ML Capital Group, Inc. [OTC:MLCG] pending FINRA approval of name and ticker ...
Silverback Therapeutics, a stealthy biotechnology startup, gave the first glimpse of its technology Wednesday as it announced an additional $37.5 million in funding, bringing its Series A round to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results